22.7K Baxter drug infusion pumps in Class I recall

The FDA labeled 22,769 Baxter drug infusion devices as a Class I recall after receiving reports of false upstream occlusion alarms, which can delay therapy.

Advertisement

The two infusion pumps, SIGMA Spectrum Infusion Pump with Master Drug Library and Spectrum IQ Infusion System with Dose IQ Safety Software, deliver pharmaceuticals, blood and blood products, and other therapies. 

Interrupted regimens can lead to serious adverse events, the FDA said Aug. 1. Baxter has reported 131 complaints, three serious injuries and zero deaths.

The medical device company notified its customers in mid-June and said it would “contact facilities to determine the correction plan and schedule a no charge software reversion for all affected pumps to the previous software version,” according to the FDA.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.